brand logo

Am Fam Physician. 2024;110(1):11

Author disclosure: No relevant financial relationships.

To the Editor:

Thank you to Dr. Quencer and colleagues for an excellent article on primary aldosteronism.1 I have two questions about testing for primary aldosteronism in patients with atrial fibrillation (AF):

  • The authors recommend testing for primary aldosteronism in all patients with AF. Is this true even when blood pressure is normal? If so, can we expect the AF to resolve if the underlying aldosterone concerns are addressed and there are no other contributing causes?

  • If a patient is normotensive, can we assume that they do not have primary aldosteronism, even with AF or other risk factors?

In Reply

We thank Dr. Dudley for these questions on case detection testing for primary aldosteronism in patients with AF. Our article states that patients with AF and hypertension should undergo case detection with measurement of the aldosterone-renin ratio.

Although the most recent Endocrine Society guidelines do not include unexplained AF as an indication for case detection, they acknowledge that some institutions measure aldosteronerenin ratio for patients with new-onset AF.1 A prospective study published in 2020 found that 42% of patients with nonvalvular AF had primary aldosteronism.2 A meta-analysis found that AF was 3.5 times more common in patients with primary aldosteronism than in those with essential hypertension.3

The rate of primary aldosteronism in patients with unexplained AF is nearly 4 times higher than the rate in patients with well-established reasons to screen for primary aldosteronism (e.g., resistant hypertension).

Proposed causal mechanisms for development of AF in patients with primary aldosteronism include cardiac fibrosis, electrical remodeling, ventricular diastolic dysfunction, and hypokalemia.4 With targeted medical or surgical treatment for primary aldosteronism, the prevalence of AF decreases to that seen in patients with essential hypertension.5 Therefore, primary aldosteronism case detection should be considered in hypertensive patients with otherwise unexplained AF.

Normotensive primary aldosteronism exists but is rare.6 It is typically discovered on workup for hypokalemia or an incidental adrenal nodule, and many of these patients develop hypertension. For practical purposes, patients with normal blood pressure do not need testing for primary aldosteronism, even with risk factors such as unexplained AF.

Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading

More in AFP

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.